Unveiling the Shadows: The Silent Epidemic of Rare Diseases in India​

The World Health Organization (WHO) defines rare diseases as those affecting 1 or fewer than 1 in every 1,000 people. However, definitions vary across countries, in India we do not have a standard criteria for categorizing these diseases. The Indian Council of Medical Research (ICMR) defines rare diseases as those affecting fewer than one person in a population of 2,500, while the Organization for Rare Diseases India (ORDI) suggests a ratio of 1 in 5,000. These conditions encompass a wide spectrum, including genetic disorders, infectious tropical diseases, rare cancers, and degenerative conditions.

Baby in the NICU? Don’t panic!

Having a newborn in the ICU can be a scary experience. While the doctors are busy caring for your child, allow us to bring you clarity about what’s going on.

Common Rare Diseases

The diagnosis is the most nerve wrecking part of the disease. Inform yourself of the warning signs to make things easier!

Get your newborn screened asap!

Rare diseases are not as rare as you think! Thankfully we have a new technology that can help detect them before it’s too late…

With a decade of diverse experience under his belt, Sameer Malik, an alumnus of the Delhi School of Economics, brings a robust blend of business strategy, finance, operations, and sales expertise to Vgenomics. From kick starting his career at KPMG to founding and scaling an e-commerce startup to over $1.5 million in annual revenues, and further contributing to the startup ecosystem through his involvement in Startup Nexus and Token Amigo, Sameer has navigated through various industries, consistently playing to his strategic and operational strengths. His rich entrepreneurial journey and strategic acumen are now channeled towards advancing Vgenomics' mission in the realm of rare inborn diseases diagnostics and therapeutic solutions.

A translational biologist based in Silicon Valley, Dr. Lal brings her expertise in data science, translational medicine, clinical biomarker, and CDx implementation across all phases of clinical trials development to Vgenomics. With over 150 patents to her name, she has substantial experience in regulatory interactions with both the drug and device divisions of the FDA, and companion diagnostics (Dx) programs.

After earning her doctorate from International Center of Genetic Engineering and Biotechnology (ICGEB), Dr. Sardar embarked on a mission to transform her research findings into practical applications that could benefit rare disease patients globally. She noticed a gap in dedicated solutions for the burgeoning hub of rare diseases in India, particularly those affecting children, and co-founded Vgenomics with Dr. Preeti to develop affordable diagnostics and therapeutic solutions.

Open chat
✉ Hey! Need Help?
Can we help you?